Jasper Therapeutics, Inc.

JSPR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$50,899$39,510$48,799$71,637
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,665$3,456$4,375$4,174
Total Curr. Assets$54,564$42,966$53,174$75,811
Property Plant & Equip (Net)$2,338$2,891$3,474$2,851
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$417$417
Tax Assets$0$0$0$0
Other NC Assets$567$609$532$820
Total NC Assets$2,905$3,500$4,423$4,088
Other Assets$0$0$0$0
Total Assets$57,469$46,466$57,597$79,899
Liabilities
Payables$9,166$8,034$2,995$4,027
Short-Term Debt$1,703$1,954$1,835$1,089
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,172$10,512$7,504$10,121
Total Curr. Liab.$21,041$20,500$12,334$15,237
LT Debt$0$201$755$724
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$24,857$2,264$2,264$2,264
Total NC Liab.$24,857$2,465$3,019$2,988
Other Liabilities$0$0$0$0
Cap. Leases$0$2,155$2,590$1,813
Total Liabilities$45,898$22,965$15,353$18,225
Equity
Pref Stock$0$0$0$0
Common Stock$3$2$2$2
Retained Earnings-$307,569-$288,833-$262,110-$240,869
AOCI$0$0$0$0
Other Equity$319,137$312,332$304,352$302,541
Total Equity$11,571$23,501$42,244$61,674
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$57,469$46,466$57,597$79,899
Net Debt-$49,196-$37,355-$46,209-$69,824
Jasper Therapeutics, Inc. (JSPR) Financial Statements & Key Stats | AlphaPilot